Skip to search formSkip to main contentSkip to account menu

ZD1694

Known as: ZD 1694, ZD-1694 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
Thymidylate synthase (TS) has been targeted in cancer therapy for many years. As a result of a prolonged and extensive drug… 
2003
2003
AIM: To investigate the effects of the thymidylate synthase(TS) inhibitor ZD 1694 against cancer cell lines in vitro . METHODS… 
2000
2000
  • 2000
  • Corpus ID: 13224268
NON-SMALL-CELL LUNG CANCER-EPIDEMIOLOGY, TUMOR MARKERS, DIAGNOSIS, STAGING, AND PROGNOSIS EPIDEMIOLOGY 1129 Gender Variations in… 
2000
2000
Purpose: Since the clinical introduction of the antifolates aminopterin (AMT) and methotrexate (MTX) many promising analogs have… 
2000
2000
Transfection of multidrug resistance proteins (MRPs) MRP1 and MRP2 in human ovarian carcinoma 2008 cells conferred a marked level… 
1999
1999
We studied the antitumor activity and toxicity of ZD1694 (tomudex), a specific inhibitor of thymidylate synthase (TS), in nude… 
1997
1997
Thymidylate synthase (TS, EC 2.1.1.45) and other folatedependent enzymes have recently received much interest as chemotherapeutic… 
1997
1997
In a previous study, we found that treatment of HCT-8 cells with ZD1694, a specific antifolate-based thymidylate synthase… 
1995
1995
'Tomudex' (ZDI694), a direct and specific thymidylate synthase (TS) inhibitor entered phase III studies in November 1993. We…